Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Cholinergic imbalance in the multiple sclerosis hippocampus.

Kooi EJ, Prins M, Bajic N, Beliën JA, Gerritsen WH, van Horssen J, Aronica E, van Dam AM, Hoozemans JJ, Francis PT, van der Valk P, Geurts JJ.

Acta Neuropathol. 2011 Sep;122(3):313-22. doi: 10.1007/s00401-011-0849-4.

2.

Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

DeKosky ST, Ikonomovic MD, Styren SD, Beckett L, Wisniewski S, Bennett DA, Cochran EJ, Kordower JH, Mufson EJ.

Ann Neurol. 2002 Feb;51(2):145-55.

PMID:
11835370
3.

Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology.

Ikonomovic MD, Mufson EJ, Wuu J, Cochran EJ, Bennett DA, DeKosky ST.

J Alzheimers Dis. 2003 Feb;5(1):39-48.

PMID:
12590165
4.

Alzheimer's disease: is the decrease of the cholinergic innervation of the hippocampus related to intrinsic hippocampal pathology?

Ransmayr G, Cervera P, Hirsch EC, Berger W, Fischer W, Agid Y.

Neuroscience. 1992;47(4):843-51.

PMID:
1374541
5.

Brain cholinergic impairment in liver failure.

García-Ayllón MS, Cauli O, Silveyra MX, Rodrigo R, Candela A, Compañ A, Jover R, Pérez-Mateo M, Martínez S, Felipo V, Sáez-Valero J.

Brain. 2008 Nov;131(Pt 11):2946-56. doi: 10.1093/brain/awn209.

6.

Deafferentation of the septo-hippocampal pathway in rats as a model of the metabolic events in Alzheimer's disease.

Krügel U, Bigl V, Eschrich K, Bigl M.

Int J Dev Neurosci. 2001 Jun;19(3):263-77.

PMID:
11337195
7.

[Effect of "Xiusanzhen" on learning-memory ability and hippocampal ChAT and AChE activity in Alzheimer disease rats].

Liu ZB, Niu WM, Yang XH, Niu XM, Wang Y.

Zhen Ci Yan Jiu. 2009 Feb;34(1):48-51. Chinese.

PMID:
19526808
8.
9.

Choline acetyltransferase and acetylcholinesterase in the hippocampus of aged rats: sensitivity to choline alphoscerate treatment.

Amenta F, Bronzetti E, Mancini M, Vega JA, Zaccheo D.

Mech Ageing Dev. 1994 May;74(1-2):47-58.

PMID:
7934207
11.

Cholinergic dysfunction in diseases with Lewy bodies.

Tiraboschi P, Hansen LA, Alford M, Sabbagh MN, Schoos B, Masliah E, Thal LJ, Corey-Bloom J.

Neurology. 2000 Jan 25;54(2):407-11.

PMID:
10668703
12.

Alzheimer's disease: case-control association study of polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample.

Piccardi M, Congiu D, Squassina A, Manconi F, Putzu PF, Mereu RM, Chillotti C, Del Zompo M.

Am J Med Genet B Neuropsychiatr Genet. 2007 Oct 5;144B(7):895-9.

PMID:
17503475
14.

Cholinergic enzymes in the spinal cord in Alzheimer-type dementia.

Yates CM, Simpson J, Gordon A, Christie JE.

J Neural Transm Park Dis Dement Sect. 1989;1(4):311-5.

PMID:
2532018
15.

Decrease in membrane-bound G4 form of acetylcholinesterase in postmortem Alzheimer brain.

Schegg KM, Nielsen S, Zweig RM, Peacock JH.

Prog Clin Biol Res. 1989;317:437-52.

PMID:
2602428
16.
17.

Cholinergic markers in the cortex and hippocampus of some animal species and their correlation to Alzheimer's disease.

Orta-Salazar E, Cuellar-Lemus CA, Díaz-Cintra S, Feria-Velasco AI.

Neurologia. 2014 Oct;29(8):497-503. doi: 10.1016/j.nrl.2012.10.007. Review. English, Spanish.

19.

Convergent cholinergic activities in aging and Alzheimer's disease.

Perry EK, Johnson M, Kerwin JM, Piggott MA, Court JA, Shaw PJ, Ince PG, Brown A, Perry RH.

Neurobiol Aging. 1992 May-Jun;13(3):393-400.

PMID:
1625768
20.

Neuroprotective efficacy of curcumin in arsenic induced cholinergic dysfunctions in rats.

Yadav RS, Chandravanshi LP, Shukla RK, Sankhwar ML, Ansari RW, Shukla PK, Pant AB, Khanna VK.

Neurotoxicology. 2011 Dec;32(6):760-8. doi: 10.1016/j.neuro.2011.07.004.

PMID:
21839772
Items per page

Supplemental Content

Support Center